Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

iCarbonX Leads $200 Million Funding in SomaLogic of Colorado

publication date: Jan 4, 2018

SomaLogic of Boulder, Colorado capped its $200 million funding round, anchored by China's iCarbonX and joined by Nan Fung Life Sciences and Madryn Asset Management. SomaLogic measures the levels of human proteins in an individual as a tool for managing their health and wellness. The company's SOMAscan® technology, which currently measures 5,000 proteins per sample, has analyzed more than 150,000 samples across more than 50 diseases or conditions. It plans to complete another 1 million samples by the end of 2020. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital